The high-NOTCH2 expression group showed significant enrichment in multiple tumor-promoting pathways, including PI3K-AKT, TGF-β, MAPK, mTOR, and KEAP1-NFE2L2 signaling. This evidence concerns the gene NFE2L2 and neoplasm.